Asterias Biotherapeutics, Inc.: 10-Q filed 2014-05-12

Name: Asterias Biotherapeutics, Inc.: 10-Q filed 2014-05-12
Creator: Asterias Biotherapeutics, Inc.

What Asterias Biotherapeutics, Inc. reported in its quarterly report filed 2014-05-12 (fiscal Q1 2014): 37 published measures, 100 facts as tagged in accession 0001140361-14-020013.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-05-12
Fiscal period: fiscal Q1 2014
Accession: 0001140361-14-020013 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Asterias Biotherapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-03-31	72,013,067	USD
At 2013-12-31	80,353,797	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-03-31	23,022,950	USD
At 2013-12-31	26,573,312	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-03-31	325,771	USD
At 2013-12-31	2,171,113	USD
At 2013-03-31	0	USD
At 2012-12-31	0	USD
At 2012-09-23	0	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-2,286,749	USD	90
2012-09-24 to 2014-03-31	-25,425,386	USD	554
2013-01-01 to 2013-12-31	-22,379,744	USD	365
2013-01-01 to 2013-03-31	-815,480	USD	90
2012-09-24 to 2012-12-31	-758,893	USD	99

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,448,884	USD	90
2012-09-24 to 2014-03-31	-2,776,015	USD	554
2013-01-01 to 2013-03-31	54,423	USD	90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	96,458	USD	90
2012-09-24 to 2014-03-31	1,343,187	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	61,980	USD	90
2012-09-24 to 2014-03-31	61,980	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	0	USD	90
2012-09-24 to 2014-03-31	4,771,896	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-396,458	USD	90
2012-09-24 to 2014-03-31	-1,670,110	USD	554
2013-01-01 to 2013-03-31	-54,423	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-03-31	-25,425,386	USD
At 2013-12-31	-23,138,637	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,349,026	USD	90
2012-09-24 to 2014-03-31	-4,629,721	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2014-03-31	1,426,397	USD
At 2013-12-31	1,460,518	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	258,674	USD	90
2012-09-24 to 2014-03-31	962,408	USD	554
2013-01-01 to 2013-03-31	2,450	USD	90

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-3,631,640	USD	90
2012-09-24 to 2014-03-31	-30,051,649	USD	554
2013-01-01 to 2013-03-31	-815,480	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-03-31	42,250,545	USD
At 2013-12-31	50,131,729	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-03-31	16,094,428	USD
At 2013-12-31	18,295,764	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-03-31	486,242	USD
At 2013-12-31	567,140	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2014-03-31	27,566,159	USD
At 2013-03-31	28,291,584	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	3,693,620	USD	90
2012-09-24 to 2014-03-31	30,113,629	USD	554
2013-01-01 to 2013-03-31	815,480	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	2,599,146	USD	90
2012-09-24 to 2014-03-31	6,918,641	USD	554
2013-01-01 to 2013-03-31	193,444	USD	90

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-03-31	80,109,432	USD
At 2013-12-31	79,850,758	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2014-03-31	-5,696,979	USD
At 2013-12-31	-2,934,686	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2014-03-31	48,990,117	USD
At 2013-12-31	53,780,485	USD
At 2012-12-31	-757,153	USD
At 2012-09-23	0	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2014-03-31	1,777,571	USD
At 2013-12-31	1,681,113	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2014-03-31	351,174	USD
At 2013-12-31	220,595	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2014-03-31	27,566,159	USD
At 2013-12-31	28,291,584	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2014-03-31	354,423	USD
At 2013-12-31	54,423	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2014-03-31	216,486	USD
At 2013-12-31	95,885	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2014-03-31	389,637	USD
At 2013-12-31	340,092	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-3,635,775	USD	90
2012-09-24 to 2014-03-31	-30,055,107	USD	554
2013-01-01 to 2013-03-31	-815,480	USD	90

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-5,049,042	USD	90
2012-09-24 to 2014-03-31	-31,122,365	USD	554
2013-01-01 to 2013-03-31	-815,820	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	1,094,474	USD	90
2012-09-24 to 2014-03-31	5,736,222	USD	554
2013-01-01 to 2013-03-31	622,036	USD	90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	130,579	USD	90
2012-09-24 to 2014-03-31	351,174	USD	554
2013-01-01 to 2013-03-31	10,904	USD	90

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	725,425	USD	90
2012-09-24 to 2014-03-31	1,450,850	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-4,135	USD	90
2012-09-24 to 2014-03-31	-3,458	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-1,349,026	USD	90
2012-09-24 to 2014-03-31	-4,629,721	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2014-01-01 to 2014-03-31	-80,898	USD	90
2012-09-24 to 2014-03-31	486,242	USD	554
2013-01-01 to 2013-03-31	0	USD	90

Inspect the source

Entity: Asterias Biotherapeutics, Inc. / CIK 0001572552
Captured: 2026-09-22 19:52 UTC
SEC response SHA-256: a511c0c6ea8b9e3680586772ced1418809b57da9984a853e990025f4a7b5d2bb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001572552.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))